Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

LifeTech Scientific Corporation (LFTSF)

Compare
0.2335
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for LFTSF
  • Previous Close 0.0000
  • Open 0.2335
  • Bid 0.1638 x --
  • Ask 0.2439 x --
  • Day's Range 0.2335 - 0.2335
  • 52 Week Range 0.2335 - 0.2335
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 1.027B
  • Beta (5Y Monthly) 1.23
  • PE Ratio (TTM) 23.35
  • EPS (TTM) 0.0100
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; properties leasing business; and manufacturing and trading of medical devices, as well as offers technical, consulting, and technology services. The company was founded in 1999 and is headquartered in Shenzhen, China.

www.lifetechmed.com

1,392

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LFTSF

View More

Performance Overview: LFTSF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

LFTSF
0.00%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

LFTSF
0.00%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

LFTSF
64.08%
HANG SENG INDEX (^HSI)
1.54%

5-Year Return

LFTSF
64.08%
HANG SENG INDEX (^HSI)
1.66%

Compare To: LFTSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LFTSF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    899.38M

  • Enterprise Value

    737.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.06%

  • Return on Assets (ttm)

    2.71%

  • Return on Equity (ttm)

    4.96%

  • Revenue (ttm)

    1.3B

  • Net Income Avi to Common (ttm)

    222.39M

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    0.14%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LFTSF

View More

Company Insights: LFTSF

Research Reports: LFTSF

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.